We are delighted to share that Dr. Sébastien Mazzuri, EspeRare’s Director of Innovation, Research and Bioethics, is speaking at the International Fetal Transplantation and Immunology Society (IFeTIS) meeting in San Francisco. IFeTIS brings together clinicians, scientists, and advocates advancing in-utero cell and gene therapies; the 2025 meeting is hosted at UCSF Mission Bay on October 19–20, 2025. Learn more about the Conference program
Dr. Mazzuri’s talk, “A Points-to-Consider(P2C) Framework for Responsible Innovation,” shares practical guidance for embedding ethics, patient partnership, and translational rigor from day one of prenatal therapy programs development: helping open this new frontier of prenatal treatments responsibly.
This conversation is anchored in EspeRare’s first-of-its-kind advances in prenatal therapy with ER-004 for XLHED and its initiative to co-develop a global P2C framework to guide responsible prenatal innovation. Learn more: ER-004 Programme and Prenatal therapies : the next medical frontier & P2C .
